Skip to main content
BLLN logo
BLLN
(NASDAQ)
BillionToOne, Inc.
$93.39-- (--)
Loading... - Market loading

BillionToOne (BLLN) Stock Price & Financial Analysis

BillionToOne Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$94.45 - $99.07
52-Week High$150.44
52-Week Low$61.96
Open$97.64
Volume574.38K
Average Volume (3M)777.27K
Market Cap4.95B
Shares Outstanding53.03M
P/E Ratio (TTM)162.28
Price to Sales (P/S)13.97
Price to Book (P/B)9.79
EV/EBITDA120.28
Revenue (TTM)354.54M
Net Income (TTM)30.52M
Free Cash Flow (TTM)26.35M
EPS (TTM)$0.83
Profit Margin8.61%
Operating Margin10.20%
Return on Equity (ROE)6.04%
Debt to Equity0.19
50-Day MA$115.95
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BillionToOne

What is the current stock price for BLLN?

As of the latest trading session, BLLN stock trades at $97.94. The 52-week range is $61.96–$150.44, with a day range of $94.45–$99.07.

What is the P/E ratio for BLLN?

BillionToOne's trailing P/E ratio is 162.3, meaning investors pay $162.3 for every $1 of annual earnings. BillionToOne operates in the Healthcare sector.

Does BLLN pay dividends?

BillionToOne does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLLN?

Based on 2 analysts, the consensus for BLLN is Buy.

What is the market cap of BLLN?

BillionToOne's market capitalization is $5.19B, classifying it as a mid-cap company. BillionToOne operates in the Healthcare sector within the Diagnostics & Research industry.